1Therapeutic Goods (Listing) Notice 2010 (No. 4)

Image unavailable in extracted text

Therapeutic Goods Act 1989

Therapeutic Goods (Listing) Notice 2010 (No. 4)

I, ROHAN HAMMETT, National Manager, Therapeutic Goods Administration, delegate of the Minister for Health and Ageing for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:

• oral preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that:
  • contain Docosahexaenoic acid (DHA)-rich oil derived from microalgae Schizochytrium sp. as a therapeutically active ingredient in combination with other ingredients; and
  • are presented in a therapeutic dosage form for therapeutic use.

This Notice commences on the day after it is registered on the Federal Register of Legislative Instruments.

Pursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.

Dated this 30th day of November 2010

(signed by)

Rohan Hammett

Delegate of the Minister for Health and Ageing